drugset / Trial / NCT00806234
Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics
Phase 4
Completed
127 enrolled
Johns Hopkins University
National Institute of Mental Health (NIMH) · collabThe Zucker Hillside Hospital · collabUniversity of Maryland · collabUniversity of North Carolina, Chapel Hill · collab
RandomizedFactorialSingle-blindTreatment
Summary
This study will test the effectiveness of two different treatments for children and adolescents who have gained weight on their antipsychotic medications.
Timeline
- Start
- 2009-01
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aripiprazole | Other / unclassified | — | — |
| Subject | Metformin | Small molecule | — | — |
| Subject | Perphenazine | Small molecule | — | — |
| Comparator | Aripiprazole | Other / unclassified | — | — |
| Comparator | Asenapine | Other / unclassified | — | — |
| Comparator | Iloperidone | Small molecule | — | — |
| Comparator | Lurasidone | Small molecule | — | — |
| Comparator | Olanzapine | Small molecule | — | — |
| Comparator | Paliperidone | Unknown | — | — |
| Comparator | Quetiapine | Small molecule | — | — |
| Comparator | Risperidone | Other / unclassified | — | — |
| Comparator | Ziprasidone | Small molecule | — | — |
| Comparator | olanzapine/fluoxetine | Unknown | — | — |